Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myeloid leukemia

被引：0
|
作者：
Fathi, Amir Tahmasb
Arevalo, Mabel
Gutierrez, Sonia
Molero, Antonieta
Sacilotto, Natalia
Limon, Ana E.
Faller, Douglas V.
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[2] Oryzon Genom, Barcelona, Spain
[3] 69 Parkton Rd, Boston, MA USA
[4] Oryzon Genom, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7075
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gilteritinib Monotherapy in Relapsed or Refractory Acute Myeloid Leukemia Flt3+in Adult Patients
    Bondarenko, Sergey
    Morozova, Elena
    Smirnova, Anna
    Vlasova, Yuliya
    Ayubova, Bella
    Karyagina, Elena
    Ilyasov, Ridvan
    Zorina, Natalia
    Belyaeva, Svetlana
    Tsvetkov, Nikolai
    Oleynikova, Yulia
    Barkhatov, Ildar
    Gindina, Tatiana
    Moiseev, Ivan
    Kulagin, Alexander
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 188 - 188
  • [22] Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
    McCall, David
    Roth, Michael
    Mahadeo, Kris M.
    Toepfer, Laurie
    Nunez, Cesar
    Short, Nicholas J.
    Daver, Naval
    Kadia, Tapan M.
    DiNardo, Courtney
    Yi, Joanna S.
    Cuglievan, Branko
    BLOOD ADVANCES, 2021, 5 (23) : 5215 - 5219
  • [23] Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients
    Boluda, Blanca
    Martinez-Cuadron, David
    Algarra, Lorenzo
    Cano, Isabel
    Sayas, Maria J.
    Acuna-Cruz, Evelyn
    Blanco, Albert
    Marco-Ayala, Javier
    DeLapuerta, Rosalia
    Diaz-Gonzalez, Alvaro
    Tormo, Mar
    Rodriguez-Veiga, Rebeca
    Garcia, Raimundo
    Pinana, Jose L.
    Lopez-Pavia, Maria
    Barragan, Eva
    Amigo, Maria L.
    Sargas, Claudia
    Lopez, Aurelio
    Solana-Altabella, Antonio
    Gil, Cristina
    Eduardo Megias-Vericat, Juan
    Sanz, Miguel A.
    Montesinos, Pau
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2727 - 2736
  • [24] Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis
    Shai Shimony
    Jonathan Canaani
    Eitan Kugler
    Boaz Nachmias
    Ron Ram
    Israel Henig
    Avraham Frisch
    Chezi Ganzel
    Vladimir Vainstein
    Yakir Moshe
    Shlomzion Aumann
    Moshe Yeshurun
    Yishai Ofran
    Pia Raanani
    Ofir wolach
    Annals of Hematology, 2022, 101 : 2001 - 2010
  • [25] Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia
    Kugler, Eitan
    Cohen, Inbar
    Amitai, Irina
    Ram, Ron
    Frisch, Avraham
    Nachmias, Boaz
    Canaani, Jonathan
    Moshe, Yakir
    Krayem, Baher
    Aumann, Shlomzion
    Henig, Israel
    Vainstein, Vladimir
    Shargian, Liat
    Ganzel, Chezi
    Yeshurun, Moshe
    Levi, Itay
    Raanani, Pia
    Akria, Luiza
    Ofran, Yishai
    Shimony, Shai
    Wolach, Ofir
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 932 - 941
  • [26] Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia
    Chen, Nianci
    Pan, Jiajia
    Zhou, Yile
    Mao, Liping
    Lou, Yinjun
    Qian, Jiejing
    Xu, Gaixiang
    Wei, Juying
    Zhou, De
    Shou, Lihong
    Huang, Li
    Yan, Minchao
    Zeng, Hui
    Fan, Cuihua
    Wu, Gongqiang
    Feng, Weiying
    Tong, Hongyan
    Jin, Jie
    Wang, Huafeng
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 861 - 870
  • [27] Gilteritinib or venetoclax in relapsed or refractory FLT3mut acute myeloid leukemia
    Murray, Graeme
    Bouligny, Ian Michael
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia
    Hirose, Natsuki
    Tachibana, Takayoshi
    Izumi, Akihiko
    Sato, Shuku
    Tadera, Noriyuki
    Tamai, Yotaro
    Kanamori, Heiwa
    Tanaka, Masatsugu
    Nakajima, Hideaki
    HEMATOLOGY, 2023, 28 (01)
  • [29] FLT3 Inhibitors in Combination with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia
    Bouligny, Ian
    Murray, Graeme
    Thuy Ho
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    BLOOD, 2023, 142
  • [30] Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
    Masamichi Mori
    Naoki Kaneko
    Yoko Ueno
    Masaki Yamada
    Ruriko Tanaka
    Rika Saito
    Itsuro Shimada
    Kenichi Mori
    Sadao Kuromitsu
    Investigational New Drugs, 2017, 35 : 556 - 565
12345